Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Significance of allelic percentage of BRAF c.1799T > A (V600E) mutation in papillary thyroid carcinoma.

Annals of surgical oncology - 1 Dec 2014

Cheng Shih-Ping, Hsu Yi-Chiung, Liu Chien-Liang, Liu Tsang-Pai, Chien Ming-Nan, Wang Tao-Yeuan, Lee Jie-Jen

Abstract excerpt

BACKGROUND: Somatic BRAF mutation is frequently observed in papillary thyroid carcinoma (PTC). Recent evidence suggests that PTCs are heterogeneous tumors containing a subclonal or oligoclonal occurrence of BRAF mutation. Conflicting results have been reported concerning the prognostic significance of the mutant allele frequency. Our present aim was to investigate the association between the percentage of BRAF...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma
Share to Carcinoma, Papillary

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotyping Techniques

Share to Mass Spectrometry

Share to Neoplasm Invasiveness

Share to Thyroid Cancer, Papillary

Share to Thyroid Neoplasms

Share to Tumor Burden

Source

Identifiers

PMID: 24748129
DOI: 10.1245/s10434-014-3723-5

Genes

BRAF

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Significance of allelic percentage of BRAF c.1799T > A (V600E) mutation in papillary thyroid carcinoma.PMID 24748129Read ↗

A high percentage of BRAFV600E alleles in papillary thyroid carcinoma predicts a poorer outcome.Semantic proximity Read ↗

Allele percentage of the BRAF V600E mutation in papillary thyroid carcinomas and corresponding lymph node metastases: no evidence for a role in tumor progression.Semantic proximity Read ↗

Quantification of BRAF V600E alleles predicts papillary thyroid cancer progression.Semantic proximity Read ↗

Association of BRAFV600E mutation with clinicopathological features of papillary thyroid carcinoma: a study on a Chinese population.Semantic proximity Read ↗

Clinical implications of the extent of BRAFV600E alleles in patients with papillary thyroid carcinoma.Semantic proximity Read ↗

The ratio of BRAFV600E alleles can be used to assess the biological behavior of papillary thyroid carcinomaSemantic proximity Read ↗

Prevalence, tumorigenic role, and biochemical implications of rare BRAF alterations.Semantic proximity Read ↗

Concomitant BRAF(V600E) mutation and RET/PTC rearrangement is a frequent occurrence in papillary thyroid carcinoma.Semantic proximity Read ↗

Mutant BRAF(T1799A) can be detected in the blood of papillary thyroid carcinoma patients and correlates with disease status.Semantic proximity Read ↗

BRAF V600E mutation in papillary thyroid carcinoma: significant association with node metastases and extra thyroidal invasion.Semantic proximity Read ↗

Prevalence and Clinicopathological Significance of BRAF V600E Mutation in Papillary Thyroid Carcinoma: A Retrospective Cohort Study from Kerala, IndiaSemantic proximity Read ↗

BRAF (V600E) mutation analysis in papillary thyroid carcinomas by peptide nucleic acid clamp real-time PCR.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.